- STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and moreVertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorderSTAT · 19d ago↗ source
- Ebola outbreak exposes a fractured outbreak response systemThe costly threat to employer-based health care, Gen Z doctors, and more health newsSTAT · 19d ago↗ source
- Vera Therapeutics wins FDA nod for closely watched kidney disease drug<figure><div><img src="https://imgproxy.divecdn.com/f5a4VRDXQg-SwH2yBDKHbtLeyVHpX8cemnSbe-t-6xU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjI3NzEwNDk4X0F5Q…BioPharma Dive